TLR9 expression is associated with prognosis in patients with glioblastoma multiforme

Journal of Clinical Neuroscience

Volumn 19, Issue 1, 2012, Pages 75-80

  Leng, Lige ^a,b   Jiang, Tao ^b,c   Zhang, Yazhuo ^a,b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Glioblastoma; MMP2; MMP9; Prognosis; TLR9

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; GELATINASE A; GELATINASE B; INTERLEUKIN 6; STAT3 PROTEIN; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA2;

ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; BRAIN NEOPLASMS; CANCER VACCINES; CELL LINE, TUMOR; DISEASE-FREE SURVIVAL; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; OLIGODEOXYRIBONUCLEOTIDES; TOLL-LIKE RECEPTOR 9; TUMOR MARKERS, BIOLOGICAL;

EID: 84855196132     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2011.03.037     Document Type: Article

References (39)

1. M.P. Frosch, D.C. Anthony, and U.D. Girolami The central nervous system V. Kumar, A.K. Abbas, N. Fausto, Robbins and Cotran pathologic basis of disease 7th ed. 2005 Elsevier Saunders 1401 1410
2. R. Rosell, R. de Las Peñas, and C. Balaña Translational research in glioblastoma multiforme: molecular criteria for patient selection Future Oncol 4 2008 219 228 (Pubitemid 351715780)
3. N. Laperriere, L. Zuraw, and G. Cairncross Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review Radiother Oncol 64 2002 259 273 (Pubitemid 35254019)
4. P.R. Walker, T. Calzascia, and N. de Tribolet T-cell immune responses in the brain and their relevance for cerebral malignancies Brain Res Brain Res Rev 42 2003 97 122 (Pubitemid 36549171)
5. J. Vollmer, and A.M. Krieg Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists Adv Drug Deliv Rev 61 2009 195 204
6. N. Kadowaki, S. Ho, and S. Antonenko Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens J Exp Med 194 2001 863 869 (Pubitemid 32983021)
7. A. Boonstra, R. Rajsbaum, and M. Holman Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR independent signals J Immunol 177 2006 7551 7558 (Pubitemid 44846270)
8. D.M. Klinman, A.K. Yi, and S.L. Beaucage CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma Proc Nat Acad Sci USA 93 1996 2879 2883 (Pubitemid 26116242)
9. J.M. Ilvesaro, M.A. Merrell, and L. Li Toll-like receptor 9 mediates CpG oligonucleotide induced cellular invasion Mol Cancer Res 6 2008 1534 1543
10. B. Schmausser, M. Andrulis, and S. Endrich Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori Int J Med Microbiol 295 2005 179 185 (Pubitemid 40776102)
11. D. Droemann, D. Albrecht, and J. Gerdes Human lung cancer cells express functionally active Toll-like receptor 9 Respir Res 6 2005 121 126
12. J.M. Ilvesaro, M.A. Merrell, and T.M. Swain Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro Prostate 67 2007 774 781 (Pubitemid 46709446)
13. M.A. Merrell, J.M. Ilvesaro, and N. Lehtonen Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity Mol Cancer Res 4 2006 437 447 (Pubitemid 44197039)
14. T. Ren, Z.K. Wen, and Z.M. Liu Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell: functional active role of TLR9 on tumor metastasis Cancer Biol Ther 6 2007 1704 1709 (Pubitemid 351590304)
15. Y. Meng, M. Kujas, and Y. Marie Expression of TLR9 within human glioblastoma J Neurooncol 88 2008 19 25
16. M.L. Bondy, M.E. Scheurer, and B. Malmer Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium Cancer 113 2008 1953 1968
17. P.R. Walker, T. Calzascia, and N. de Tribolet T-cell immune responses in the brain and their relevance for cerebral malignancies Brain Res Brain Res Rev 42 2003 97 122 (Pubitemid 36549171)
18. H. Wagner The immunobiology of the TLR9 subfamily Trends Immunol 25 2004 381 386 (Pubitemid 38780955)
19. F. Takeshita, I. Gursel, and K.J. Ishii Signal transduction pathways mediated by the interaction of CpG DNA with Toll-like receptor 9 Semin Immunol 16 2004 17 22 (Pubitemid 38147429)
20. A. Andaloussi, A.M. Sonabend, and Y. Han Stimulation of TLR9 with CpG ODN enhances apoptosis of glioma and prolongs the survival of mice with experimental brain tumors Glia 54 2006 526 535 (Pubitemid 44449333)
21. Y. Lin, T. Jiang, and K. Zhou Plasma IGFBP-2 levels predict clinical outcomes of patients with high grade gliomas Neuro Oncol 11 2009 468 476
22. N. Sanai, and M.S. Berger Operative techniques for gliomas and the value of extent of resection Neurotherapeutics 6 2009 478 486
23. K.R. Hess Extent of resection as a prognostic variable in the treatment of gliomas J Neurooncol 42 1999 227 231 (Pubitemid 29322199)
24. B.C. Pang, W.H. Wan, and C.K. Lee The role of surgery in high grade glioma - is surgical resection justified? A review of the current knowledge Ann Acad Med Singapore 36 2007 358 363
25. P. Chinnaiyan, M. Wang, and A.M. Rojiani The prognostic value of nestin expression in newly diagnosed glioblastoma: report from the Radiation Therapy Oncology Group Radiat Oncol 3 2008 32 36
26. T. Reithmeier, E. Graf, and T. Piroth BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors BMC Cancer 10 2008 30 34
27. T.T. Batchelor, R.A. Betensky, and J.M. Esposito Age-dependent prognostic effects of genetic alterations in glioblastoma Clin Cancer Res 10 2004 228 233 (Pubitemid 38114184)
28. C. Wang, S. Cao, and Y. Yan TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients BMC Cancer 10 2010 415 419
29. J. Bromberg Stat proteins and oncogenesis J Clin Invest 109 2002 1139 1142 (Pubitemid 34496590)
30. P.C. Heinrich, I. Behrmann, and S. Haan Principles of interleukin (IL)-6-type cytokine signalling and its regulation Biochem J 374 2003 1 20 (Pubitemid 37046923)
31. N.J. Van, and E.N. Benveniste Interleukin-6 expression and regulation in astrocytes J Neuroimmunol 100 1999 124 139 (Pubitemid 30038246)
32. M.E. Van, Y. Sawamura, and A.C. Diserens Human glioblastoma cells release interleukin 6 in vivo and in vitro Cancer Res 50 1990 6683 6688 (Pubitemid 20348800)
33. W.N.J. Van, J.W. Oh, and P. Repovic Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor J Neurosci 19 1999 5236 5244 (Pubitemid 29300191)
34. S.O. Rahaman, P.C. Harbor, and O. Chernova Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells Oncogene 21 2002 8404 8413 (Pubitemid 36054883)
35. L.K. Schaefer, D.G. Menter, and T.S. Schaefer Activation of stat3 and stat1 DNA binding and transcriptional activity in human brain tumour cell lines by gp130 cytokines Cell Signal 12 2000 143 151 (Pubitemid 30126031)
36. P. Repovic, C.Y. Fears, and C.L. Gladson Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells Oncogene 22 2003 8117 8124 (Pubitemid 37487302)
37. S.H. Chen, G.Y. Gillespie, and E.N. Benveniste Divergent effects of oncostatin M on astroglioma cells: influence on cell proliferation, invasion, and expression of matrix metalloproteinases Glia 53 2006 191 200
38. E. Briceno, A. Calderon, and J. Sotelo Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme Surg Neurol 67 2007 388 391 (Pubitemid 46365851)
39. E. Briceno, S. Reyes, and J. Sotelo Therapy of glioblastoma multiforme improved by the antimutagenic chloroquine Neurosurg Focus 14 2003 E3